Deep Brain Stimulation for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this pilot study is to assess changes in thinking and movement after deep brain stimulator implantation. The study will also examine whether these changes are related to the risk of falls.
Are You a Good Fit for This Trial?
This trial is for people aged 30-80 with Parkinson's disease who have chosen to get deep brain stimulation (DBS) surgery because their symptoms aren't controlled by medication. Participants must be able to walk and be cleared for DBS surgery, and available for follow-up.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-Surgery Observation
Participants are observed prior to DBS surgery to collect baseline data on falls and step count
Post-Surgery Observation
Participants are observed after DBS surgery to assess changes in thinking, movement, and fall risk
Follow-up
Participants are monitored for safety and effectiveness after the observation period
What Are the Treatments Tested in This Trial?
Interventions
- Deep Brain Stimulation (DBS)
Trial Overview
The study looks at how thinking and movement change after DBS surgery in people with Parkinson's disease, and whether these changes affect the risk of falling. All participants receive DBS as part of standard care.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Individuals who undergo DBS surgery as part of standard of care will be observed prior to and after DBS surgery and data at these timepoints associated with indicine falls.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.